glutamic acid has been researched along with Bone Cancer in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, J; Jiang, Z; Liu, Y; Su, Y; Sun, Y; Tong, S; Zhang, J; Zhang, Y; Zhao, D | 1 |
| Xie, C; Yang, Y; Zhao, Y; Zhao, Z | 1 |
| Chen, C; Cui, X; Guo, Z; Lin, D; Wang, S; Xie, C; Zhao, Y; Zhao, Z; Zhou, J | 1 |
| BassiriRad, NM; Bui, L; Doyle, T; Forte, BL; Largent-Milnes, TM; Mantyh, PW; Neumann, WL; Salvemini, D; Slosky, LM; Staatz, WD; Symons, AM; Thompson, M; Vanderah, TW | 1 |
| Gao, Y; Huang, X; Ke, C; Li, Y; Liu, J; Luo, J; Shi, R; Xu, X; Yao, W | 1 |
| Ait Taouit, L; Basu-Roy, U; Gulzar, H; Houssou, M; Jaikaran, T; Kozlitina, K; Liao, S; Mahajan, SS; Mansukhani, A; Ruiz, Y; Schvarts, Y; Yelskaya, Z | 1 |
| Seidlitz, EP; Sharma, MK; Singh, G | 1 |
| Kondo, A; Matsuda, T; Togari, A; Tsunashima, Y | 1 |
| Seidlitz, EP; Singh, G; Ungard, RG | 1 |
| Costa, S; Ferreira, P; Lopes, C; Medeiros, RM; Morais, A; Oliveira, J; Pinto, D; Vasconcelos, A | 1 |
| Balasenthil, S; Kumar, R; Mishra, SK; Nair, SS; Vadlamudi, RK; Yang, Z | 1 |
| Benua, RS; Gelbard, AS; Huvos, AG; Laughlin, JS; Reiman, RE; Rosen, G | 1 |
| Benua, RS; Gelbard, AS; Laughlin, JS; Reiman, RE; Rosen, G | 1 |
| Brandeis, WE; Braun, A; Georgi, P; Helus, F; Knapp, WH; Ostertag, H; Sinn, H | 1 |
| Barrientes, S; Cooke, C; Goodrich, DW | 1 |
1 review(s) available for glutamic acid and Bone Cancer
| Article | Year |
|---|---|
Oxidative stress and cancer pain.
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cysteine; Female; Glutamic Acid; Humans; Nociceptive Pain; Oxidative Stress; Reactive Oxygen Species | 2013 |
14 other study(ies) available for glutamic acid and Bone Cancer
| Article | Year |
|---|---|
Acidity-Triggered Transformable Polypeptide Self-Assembly to Initiate Tumor-Specific Biomineralization.
Topics: Alendronate; Animals; Biomineralization; Bone Neoplasms; Cell Line, Tumor; Glutamic Acid; Mice; Nanoparticles; Osteosarcoma; Peptides; Tumor Microenvironment | 2023 |
Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Folic Acid; Glutamic Acid; Humans; Ligands; Liposomes; Oligopeptides; Rats; Wound Healing | 2020 |
Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cell Proliferation; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Glutamic Acid; Humans; Ligands; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Oligopeptides; Paclitaxel; Tumor Cells, Cultured | 2019 |
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiporters; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Heterografts; Metalloporphyrins; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Sulfasalazine; Time Factors | 2016 |
GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain.
Topics: Animals; Bone Neoplasms; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cancer Pain; Disease Models, Animal; Female; GABAergic Neurons; Gene Expression Regulation; Glutamic Acid; Posterior Horn Cells; Rats; Receptors, G-Protein-Coupled; Receptors, GABA; Spinal Cord; Synaptic Transmission | 2016 |
Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole.
Topics: Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mice; Osteosarcoma; Receptor, Metabotropic Glutamate 5; Riluzole; Signal Transduction | 2017 |
Cancer cells release glutamate via the cystine/glutamate antiporter.
Topics: Amino Acid Transport System y+; Animals; Bone Neoplasms; Cell Line, Tumor; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Humans; Mice; Mice, Inbred Strains; Neoplasm Metastasis; RNA, Messenger; Vesicular Glutamate Transport Protein 1 | 2010 |
Inhibitory effect of vitamin K(2) on interleukin-1beta-stimulated proliferation of human osteoblasts.
Topics: Adult; Anticoagulants; Bone Neoplasms; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Flavonoids; Glutamic Acid; Humans; Imidazoles; Interleukin-1; Interleukin-1beta; Male; Mitogen-Activated Protein Kinase Kinases; Nitrobenzenes; Osteoblasts; Osteocalcin; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Pregnane X Receptor; Protein Kinase Inhibitors; Pyridines; Receptors, Steroid; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Sulfonamides; Vitamin K; Vitamins; Warfarin; Young Adult | 2010 |
Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.
Topics: Aged; Aspartic Acid; Bone Neoplasms; Disease Progression; Exons; Genotype; Glutamic Acid; Humans; Logistic Models; Male; Middle Aged; Neoplasm Metastasis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Prognosis; Prostatic Neoplasms; Treatment Outcome | 2002 |
Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
Topics: Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chromatin; Co-Repressor Proteins; Cytosol; Epitopes; Estradiol; Glutamic Acid; Histones; Humans; Nuclear Matrix; Osteosarcoma; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Protein Structure, Tertiary; Trans-Activators; Transcription Factors | 2004 |
Quotient imaging with N-13 L-glutamate in osteogenic sarcoma: correlation with tumor viability.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Female; Glutamates; Glutamic Acid; Humans; Male; Nitrogen Radioisotopes; Osteosarcoma | 1981 |
Imaging of primary Ewing sarcoma with 13N-L-glutamate.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Diphosphonates; Female; Glutamates; Glutamic Acid; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Radionuclide Imaging; Sarcoma, Ewing; Soft Tissue Neoplasms; Technetium; Technetium Tc 99m Medronate | 1982 |
N-13 L-glutamate uptake in malignancy: its relationship to blood flow.
Topics: Adolescent; Animals; Bone Neoplasms; Drug Evaluation; Glutamates; Glutamic Acid; Hindlimb; Humans; Iodine Radioisotopes; Kinetics; Male; Microspheres; Nitrogen Radioisotopes; Rabbits; Radionuclide Imaging; Rats; Rats, Inbred Strains; Regional Blood Flow; Tibial Fractures; Tissue Distribution | 1984 |
Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function.
Topics: Bone Neoplasms; Cell Cycle; Cell Line; Cyclin-Dependent Kinases; Genes, Retinoblastoma; Glutamic Acid; Humans; Kidney; Mutagenesis, Site-Directed; Osteosarcoma; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Recombinant Fusion Proteins; Retinoblastoma Protein; Serine; Structure-Activity Relationship; Threonine; Transfection; Tumor Cells, Cultured | 2000 |